A preliminary study examining the binding capacity of Akkermansia muciniphila and Desulfovibrio spp., to colonic mucin in health and ulcerative colitis

PLoS ONE

Volumn 10, Issue 10, 2015, Pages

  Earley, Helen ^a,b   Lennon, Grainne ^a,b   Balfe, Aine ^a,b   Kilcoyne, Michelle ^c   Clyne, Marguerite ^a   Joshi, Lokesh ^c   Carrington, Stephen ^a   Martin, Sean T ^b   Coffey, J Calvin ^d   Winter, Desmond C ^b   O'Connell, P Ronan ^a,b  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^c NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^d UNIVERSITY OF LIMERICK   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

COLONIC MUCIN; MUCIN; UNCLASSIFIED DRUG; LECTIN;

AKKERMANSIA MUCINIPHILA; ARTICLE; BACTERIAL PHENOMENA AND FUNCTIONS; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM MUCIN BINDING CAPACITY; CLINICAL ARTICLE; COLON CANCER; COLON RESECTION; COMMENSAL; CONTROLLED STUDY; DESULFOVIBRIO; HUMAN; HUMAN TISSUE; INTESTINE FLORA; MICROARRAY ANALYSIS; NONHUMAN; PROTEIN BINDING; PROTEIN PURIFICATION; ULCERATIVE COLITIS; CASE CONTROL STUDY; COLON; GLYCOSYLATION; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; PHYSIOLOGY; VERRUCOMICROBIA;

CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; COLON; DESULFOVIBRIO; GLYCOSYLATION; HUMANS; LECTINS; MICROARRAY ANALYSIS; MUCINS; VERRUCOMICROBIA;

EID: 84949521739     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0135280     Document Type: Article

References (60)

1. McGuckin MA, Linden SK, Sutton P, Florin TH. Mucin dynamics and enteric pathogens. Nature reviews Microbiology. 2011; 9(4):265-78. doi: 10.1038/nrmicro2538 PMID: 21407243
2. Johansson ME, Larsson JM, Hansson GC. The two mucus layers of colon are organized by the MUC2 mucin, whereas the outer layer is a legislator of host-microbial interactions. Proceedings of the National Academy of Sciences of the United States of America. 2011; 108 Suppl 1:4659-65. doi: 10.1073/pnas. 1006451107 PMID: 20615996
3. Hansson GC. Role of mucus layers in gut infection and inflammation. Current opinion in microbiology. 2012; 15(1):57-62. doi: 10.1016/j.mib.2011.11.002 PMID: 22177113
4. Backhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI. Host-bacterial mutualism in the human intestine. Science (New York, NY). 2005; 307(5717):1915-20.
5. Ouwerkerk JP, de Vos WM, Belzer C. Glycobiome: bacteria and mucus at the epithelial interface. Best practice & research Clinical gastroenterology. 2013; 27(1):25-38.
6. Backhed F. Host responses to the human microbiome. Nutrition reviews. 2012; 70 Suppl 1:S14-7. doi: 10.1111/j.1753-4887.2012.00496.x PMID: 22861802
7. Tremaroli V, Kovatcheva-Datchary P, Backhed F. A role for the gut microbiota in energy harvesting? Gut. 2010; 59(12):1589-90. doi: 10.1136/gut.2010.223594 PMID: 20940281
8. Lennon G, Balfe A, Earley H, Devane LA, Lavelle A, Winter DC, et al. Influences of the colonic microbiome on the mucous gel layer in ulcerative colitis. Gut microbes. 2014; 5(3):277-85. doi: 10.4161/gmic.28793 PMID: 24714392
9. Antoni L, Nuding S, Wehkamp J, Stange EF. Intestinal barrier in inflammatory bowel disease. World journal of gastroenterology: WJG. 2014; 20(5):1165-79. doi: 10.3748/wjg.v20.i5.1165 PMID: 24574793
10. Longman RJ, Poulsom R, Corfield AP, Warren BF, Wright NA, Thomas MG. Alterations in the composition of the supramucosal defense barrier in relation to disease severity of ulcerative colitis. The journal of histochemistry and cytochemistry: official journal of the Histochemistry Society. 2006; 54(12):1335-48.
11. Pullan RD, Thomas GA, Rhodes M, Newcombe RG, Williams GT, Allen A, et al. Thickness of adherent mucus gel on colonic mucosa in humans and its relevance to colitis. Gut. 1994; 35(3):353-9. PMID: 8150346
12. Forgue-Lafitte ME, Fabiani B, Levy PP, Maurin N, Flejou JF, Bara J. Abnormal expression of M1/MUC5AC mucin in distal colon of patients with diverticulitis, ulcerative colitis and cancer. International journal of cancer Journal international du cancer. 2007; 121(7):1543-9. PMID: 17565737
13. Larsson JM, Karlsson H, Crespo JG, Johansson ME, Eklund L, Sjovall H, et al. Altered O-glycosylation profile of MUC2 mucin occurs in active ulcerative colitis and is associated with increased inflammation. Inflammatory bowel diseases. 2011; 17(11):2299-307. PMID: 21290483
14. Schultsz C, Van Den Berg FM, Ten Kate FW, Tytgat GN, Dankert J. The intestinal mucus layer from patients with inflammatory bowel disease harbors high numbers of bacteria compared with controls. Gastroenterology. 1999; 117(5):1089-97. PMID: 10535871
15. Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, Gordon JI. The human microbiome project. Nature. 2007; 449(7164):804-10. PMID: 17943116
16. Joossens M, Huys G, Cnockaert M, De Preter V, Verbeke K, Rutgeerts P, et al. Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives. Gut. 2011; 60(5):631-7. doi: 10.1136/gut.2010.223263 PMID: 21209126
17. Morgan XC, Tickle TL, Sokol H, Gevers D, Devaney KL, Ward DV, et al. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome biology. 2012; 13(9):R79. doi: 10.1186/gb-2012-13-9-r79 PMID: 23013615
18. Natividad JM, Verdu EF. Modulation of intestinal barrier by intestinal microbiota: pathological and therapeutic implications. Pharmacological research: the official journal of the Italian Pharmacological Society. 2013; 69(1):42-51.
19. Derrien M, Vaughan EE, Plugge CM, de Vos WM. Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. International journal of systematic and evolutionary microbiology. 2004; 54(Pt 5):1469-76. PMID: 15388697
20. Derrien M, Van Baarlen P, Hooiveld G, Norin E, Muller M, de Vos WM. Modulation of Mucosal Immune Response, Tolerance, and Proliferation in Mice Colonized by the Mucin-Degrader Akkermansia muciniphila. Frontiers in microbiology. 2011; 2:166. doi: 10.3389/fmicb.2011.00166 PMID: 21904534
21. Derrien M, Collado MC, Ben-Amor K, Salminen S, de Vos WM. The Mucin degrader Akkermansia muciniphila is an abundant resident of the human intestinal tract. Applied and environmental microbiology. 2008; 74(5):1646-8. PMID: 18083887
22. Belzer C, de Vos WM. Microbes inside-from diversity to function: the case of Akkermansia. The ISME journal. 2012; 6(8):1449-58. doi: 10.1038/ismej.2012.6 PMID: 22437156
23. Reunanen J, Kainulainen V, Huuskonen L, Ottman N, Belzer C, Huhtinen H, et al. Akkermansia muciniphila Adheres to Enterocytes and Strengthens the Integrity of the Epithelial Cell Layer. Applied and environmental microbiology. 2015; 81(11):3655-62. doi: 10.1128/AEM.04050-14 PMID: 25795669
24. Png CW, Linden SK, Gilshenan KS, Zoetendal EG, McSweeney CS, Sly LI, et al. Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. The American journal of gastroenterology. 2010; 105(11):2420-8. doi: 10.1038/ajg.2010.281 PMID: 20648002
25. James SL, Christophersen CT, Bird AR, Conlon MA, Rosella O, Gibson PR, et al. Abnormal fibre usage in UC in remission. Gut. 2015; 64(4):562-70. doi: 10.1136/gutjnl-2014-307198 PMID: 25037189
26. Roediger WE, Duncan A, Kapaniris O, Millard S. Sulphide impairment of substrate oxidation in rat colonocytes: a biochemical basis for ulcerative colitis? Clinical science (London, England: 1979). 1993; 85 (5):623-7.
27. Roediger WE, Moore J, Babidge W. Colonic sulfide in pathogenesis and treatment of ulcerative colitis. Digestive diseases and sciences. 1997; 42(8):1571-9. PMID: 9286219
28. Pitcher MC, Beatty ER, Cummings JH. The contribution of sulphate reducing bacteria and 5-aminosalicylic acid to faecal sulphide in patients with ulcerative colitis. Gut. 2000; 46(1):64-72. PMID: 10601057
29. Jia W, Whitehead RN, Griffiths L, Dawson C, Bai H, Waring RH, et al. Diversity and distribution of sulphate-reducing bacteria in human faeces from healthy subjects and patients with inflammatory bowel disease. FEMS immunology and medical microbiology. 2012; 65(1):55-68. doi: 10.1111/j.1574-695X. 2012.00935.x PMID: 22309113
30. Rowan F, Docherty NG, Murphy M, Murphy B, Calvin Coffey J, O'Connell PR. Desulfovibrio bacterial species are increased in ulcerative colitis. Diseases of the colon and rectum. 2010; 53(11):1530-6. PMID: 20940602
31. Attene-Ramos MS, Nava GM, Muellner MG, Wagner ED, Plewa MJ, Gaskins HR. DNA damage and toxicogenomic analyses of hydrogen sulfide in human intestinal epithelial FHs 74 Int cells. Environmental and molecular mutagenesis. 2010; 51(4):304-14. doi: 10.1002/em.20546 PMID: 20120018
32. Kilcoyne M, Gerlach JQ, Gough R, Gallagher ME, Kane M, Carrington SD, et al. Construction of a natural mucin microarray and interrogation for biologically relevant glyco-epitopes. Analytical chemistry. 2012; 84(7):3330-8. doi: 10.1021/ac203404n PMID: 22390135
33. Naughton JA, Marino K, Dolan B, Reid C, Gough R, Gallagher ME, et al. Divergent mechanisms of interaction of Helicobacter pylori and Campylobacter jejuni with mucus and mucins. Infection and immunity. 2013; 81(8):2838-50. doi: 10.1128/IAI.00415-13 PMID: 23716616
34. Fite A, Macfarlane GT, Cummings JH, Hopkins MJ, Kong SC, Furrie E, et al. Identification and quantitation of mucosal and faecal desulfovibrios using real time polymerase chain reaction. Gut. 2004; 53 (4):523-9. PMID: 15016746
35. Lennon G, Balfe A, Bambury N, Lavelle A, Maguire A, Docherty NG, et al. Correlations between colonic crypt mucin chemotype, inflammatory grade and Desulfovibrio species in ulcerative colitis. Colorectal disease: the official journal of the Association of Coloproctology of Great Britain and Ireland. 2014; 16 (5):O161-9.
36. Geboes K, Riddell R, Ost A, Jensfelt B, Persson T, Lofberg R. A reproducible grading scale for histological assessment of inflammation in ulcerative colitis. Gut. 2000; 47(3):404-9. PMID: 10940279
37. Kilcoyne M, Twomey ME, Gerlach JQ, Kane M, Moran AP, Joshi L. Campylobacter jejuni strain discrimination and temperature-dependent glycome expression profiling by lectin microarray. Carbohydrate research. 2014; 389:123-33. doi: 10.1016/j.carres.2014.02.005 PMID: 24680511
38. van Passel MW, Kant R, Zoetendal EG, Plugge CM, Derrien M, Malfatti SA, et al. The genome of Akkermansia muciniphila, a dedicated intestinal mucin degrader, and its use in exploring intestinal metagenomes. PloS one. 2011; 6(3):e16876. doi: 10.1371/journal.pone.0016876 PMID: 21390229
39. Mello LV, Chen X, Rigden DJ. Mining metagenomic data for novel domains: BACON, a new carbohydrate-binding module. FEBS letters. 2010; 584(11):2421-6. doi: 10.1016/j.febslet.2010.04.045 PMID: 20416301
40. Boraston AB, Bolam DN, Gilbert HJ, Davies GJ. Carbohydrate-binding modules: fine-tuning polysaccharide recognition. The Biochemical journal. 2004; 382(Pt 3):769-81. PMID: 15214846
41. Tang Z, Chen H, Chen L, Liu S, Han X, Wu Q. Improving endoglucanase activity by adding the carbohydrate-binding module from Corticium rolfsii. Journal of microbiology and biotechnology. 2014; 24 (4):440-6. PMID: 24375414
42. Guillen D, Sanchez S, Rodriguez-Sanoja R. Carbohydrate-binding domains: multiplicity of biological roles. Applied microbiology and biotechnology. 2010; 85(5):1241-9. doi: 10.1007/s00253-009-2331-y PMID: 19908036
43. Gao S, You C, Renneckar S, Bao J, Zhang YH. New insights into enzymatic hydrolysis of heterogeneous cellulose by using carbohydrate-binding module 3 containing GFP and carbohydrate-binding module 17 containing CFP. Biotechnology for biofuels. 2014; 7(1):24. doi: 10.1186/1754-6834-7-24 PMID: 24552554
44. Ouwehand AC, Suomalainen T, Tölkkö S, Salminen S. In vitro adhesion of propionic acid bacteria to human intestinal mucus. Lait. 2002; 82(1):123-30.
45. Del Re B, Sgorbati B, Miglioli M, Palenzona D. Adhesion, autoaggregation and hydrophobicity of 13 strains of Bifidobacterium longum. Letters in Applied Microbiology. 2000; 31(6):438-42. PMID: 11123552
46. McCann JR, Sheets AJ, Grass S, St Geme JW. The Haemophilus Cryptic Genospecies Cha Adhesin Has at Least Two Variants That Differ in Host Cell Binding, Bacterial Aggregation, and Biofilm Formation Properties. Journal of bacteriology. 2014; 196(9):1780-8. doi: 10.1128/JB.01409-13
47. Kline KA, Fälker S, Dahlberg S, Normark S, Henriques-Normark B. Bacterial Adhesins in Host-Microbe Interactions. Cell host & microbe. 2009; 5(6):580-92.
48. Prorok-Hamon M, Friswell MK, Alswied A, Roberts CL, Song F, Flanagan PK, et al. Colonic mucosaassociated diffusely adherent afaC plus Escherichia coli expressing lpfA and pks are increased in inflammatory bowel disease and colon cancer. Gut. 2014; 63(5):761-70. doi: 10.1136/gutjnl-2013-304739 PMID: 23846483
49. Hsu K-L, Pilobello KT, Mahal LK. Analyzing the dynamic bacterial glycome with a lectin microarray approach. Nat Chem Biol. 2006; 2(3):153-7. PMID: 16462751
50. Harris SL, Spears PA, Havell EA, Hamrick TS, Horton JR, Orndorff PE. Characterization of Escherichia coli Type 1 Pilus Mutants with Altered Binding Specificities. Journal of bacteriology. 2001; 183 (13):4099-102. PMID: 11395476
51. Mahdavi J, Royer P-J, Sjölinder HS, Azimi S, Self T, Stoof J, et al. Pro-inflammatory cytokines can act as intracellular modulators of commensal bacterial virulence. Open Biology. 2013; 3(10).
52. Raouf AH, Tsai HH, Parker N, Hoffman J, Walker RJ, Rhodes JM. Sulphation of colonic and rectal mucin in inflammatory bowel disease: reduced sulphation of rectal mucus in ulcerative colitis. Clinical science (London, England: 1979). 1992; 83(5):623-6.
53. Corfield AP, Myerscough N, Bradfield N, Corfield Cdo A, Gough M, Clamp JR, et al. Colonic mucins in ulcerative colitis: evidence for loss of sulfation. Glycoconjugate journal. 1996; 13(5):809-22. PMID: 8910008
54. Tsai HH, Dwarakanath AD, Hart CA, Milton JD, Rhodes JM. Increased faecal mucin sulphatase activity in ulcerative colitis: a potential target for treatment. Gut. 1995; 36(4):570-6. PMID: 7737566
55. Corfield AP, Wagner SA, Clamp JR, Kriaris MS, Hoskins LC. Mucin degradation in the human colon: production of sialidase, sialate O-acetylesterase, N-acetylneuraminate lyase, arylesterase, and glycosulfatase activities by strains of fecal bacteria. Infection and immunity. 1992; 60(10):3971-8. PMID: 1398908
56. Carrington SD, Irwin JA, Liu L, Rudd PM, Matthews E, Corfield AP. Analysing mucin degradation. Methods in molecular biology (Clifton, NJ). 2012; 842:191-215.
57. Klein A, Roussel P. O-acetylation of sialic acids. Biochimie. 1998; 80(1):49-57. PMID: 9587662
58. Corfield AP, Myerscough N, Warren BF, Durdey P, Paraskeva C, Schauer R. Reduction of sialic acid O-acetylation in human colonic mucins in the adenoma-carcinoma sequence. Glycoconjugate journal. 1999; 16(6):307-17. PMID: 10579699
59. Shen Y, Tiralongo J, Kohla G, Schauer R. Regulation of sialic acid O-acetylation in human colon mucosa. Biological chemistry. 2004; 385(2):145-52. PMID: 15101557
60. Skoog EC, Sjoling A, Navabi N, Holgersson J, Lundin SB, Linden SK. Human gastric mucins differently regulate Helicobacter pylori proliferation, gene expression and interactions with host cells. PloS one. 2012; 7(5):e36378. doi: 10.1371/journal.pone.0036378 PMID: 22563496